(Q43480024)

23 November 2017

Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction (English)

1 reference

23 November 2017

1 reference

ventricular remodeling

1 reference

2

John R Teerlink

1 reference

23 November 2017

Marina R Bergman

1

1 reference

23 November 2017

Rajeev Mahimkar

3

1 reference

23 November 2017

Luyi Li

4

1 reference

23 November 2017

Bo-Qing Zhu

5

1 reference

23 November 2017

Anita Nguyen

6

1 reference

23 November 2017

Sia Dahi

7

1 reference

23 November 2017

Joel S Karliner

8

1 reference

23 November 2017

David H Lovett

9

1 reference

23 November 2017

8 December 2006

1 reference

American Journal of Physiology Heart and Circulatory Physiology

23 November 2017

1 reference

23 November 2017

292

1 reference

23 November 2017

4

1 reference

23 November 2017

H1847-60

1 reference

Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells

23 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Curcumin ameliorates left ventricular function in rabbits with pressure overload: inhibition of the remodeling of the left ventricular collagen network associated with suppression of myocardial tumor necrosis factor-alpha and matrix metalloproteinas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Gelatinase A (MMP-2) is necessary and sufficient for renal tubular cell epithelial-mesenchymal transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Cardiac remodeling and failure From molecules to man (Part II).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Membrane type-1 matrix metalloproteinase (MT1-MMP) exhibits an important intracellular cleavage function and causes chromosome instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Targeted deletion of MMP-2 attenuates early LV rupture and late remodeling after experimental myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Disruption of the myocardial extracellular matrix leads to cardiac dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Mitochondrial abnormalities in tumor necrosis factor-alpha-induced heart failure are associated with impaired DNA repair activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

MMP induction and inhibition in myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Circulating level of gelatinase activity predicts ventricular remodeling in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Selective disruption of MMP-2 gene exacerbates myocardial inflammation and dysfunction in mice with cytokine-induced cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Increased circulating matrix metalloproteinase-2 in patients with hypertrophic cardiomyopathy with systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Ultrastructural and molecular changes in the left and right ventricular myocardium associated with ascites syndrome in broiler chickens raised at low altitude

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Aldosterone stimulates matrix metalloproteinases and reactive oxygen species in adult rat ventricular cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of Angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Degradation of myosin light chain in isolated rat hearts subjected to ischemia-reperfusion injury: a new intracellular target for matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Microtubule-dependent matrix metalloproteinase-2/matrix metalloproteinase-9 exocytosis: prerequisite in human melanoma cell invasion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinases: a therapeutic target in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinases: regulation and dysregulation in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Mislocalization and unconventional functions of cellular MMPs in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Aldosterone-induced inflammation in the rat heart : role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Determination of protease cleavage site motifs using mixture-based oriented peptide libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Cardiac transgenic matrix metalloproteinase-2 expression directly induces impaired contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Circulating matrix metalloproteinase-2 is elevated in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

Intracellular Action of Matrix Metalloproteinase-2 Accounts for Acute Myocardial Ischemia and Reperfusion Injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00434.2006

10.1152/AJPHEART.00434.2006

21 January 2018

Identifiers

DOI

1 reference

23 November 2017

1 reference